80Bites Mobile App Release
14 août 2023 09h03 HE
|
PhysicalMind Institute
NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- PhysicalMind Institute, the company that helped bring Pilates to worldwide fame, announces the release of the 80Bites mobile application which helps an...
Study Finds Benefits of Telephone Cognitive Behavioural Therapy for Bariatric Surgery Patients
03 août 2023 11h00 HE
|
Obesity Canada
TORONTO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- New research looking at the mental health and eating behaviours of patients 1-year after bariatric surgery has found that a short, 7-session telephone...
A Call for Help from Physician Specialists on the Frontline Treating MASLD/MASH
18 juil. 2023 09h29 HE
|
Spherix Global Insights
Exton, Pennsylvania, July 18, 2023 (GLOBE NEWSWIRE) -- Data from the Centers for Disease Control & Prevention (CDC) suggests just over seventy percent of American adults are overweight,...
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
13 juil. 2023 11h00 HE
|
Cardiometabolic Health Congress
Boca Raton, FL, July 13, 2023 (GLOBE NEWSWIRE) -- The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization. A vast collection of webinars, CME...
Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine's Scientific Advisory Board
11 juil. 2023 08h30 HE
|
Clearmind Medicine Inc.
Tel Aviv, Israel/Vancouver, Canada, July 11, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "Company"), a biotech company focused on discovery...
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
03 juil. 2023 06h01 HE
|
Zealand Pharma
Company announcement – No. 27 / 2023 Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 Doses of 0.6 and 1.2 mg ZP8396...
Obesity Market to Witness a Robust Growth by 2032, Assesses DelveInsight | Key Companies to Watch Out - Amgen, Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer, Raziel, Altimmune, Saniona, YSOPIA, Innovent
27 juin 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, June 27, 2023 (GLOBE NEWSWIRE) -- Obesity Market to Witness a Robust Growth by 2032, Assesses DelveInsight | Key Companies to Watch Out - Amgen, Novo Nordisk, Eli Lilly and Company,...
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
24 juin 2023 11h35 HE
|
Zealand Pharma
Press release – No. 6 / 2023 Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions Body weight reductions reached up to a mean...
Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)
23 juin 2023 17h15 HE
|
Zealand Pharma
Press Release No. 5 / 2023 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with...
SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesity and Metabolic Syndrome
16 juin 2023 09h05 HE
|
SciSparc Ltd
The treatment combines SciSparc's Palmitoylethanolamide (PEA), the active pharmaceutical ingredient of its proprietary CannAmide™, and Clearmind’s MEAI, a novel proprietary psychedelic treatment for...